← Back to Treatments
🏅 FDA Orphan Designation

Roferon-A

Interferon alfa-2a (recombinant)

Manufacturer: Hoffmann-La Roche, Inc.

Indicated for:
OBSOLETE: HIV-related Kaposi sarcomaOrphan

FDA-Approved Indications (1)

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.